drugset / Trial / NCT00834210
Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris
RandomizedParallel-groupSingle-blindTreatment
Summary
A 12-week evaluation of the safety and efficacy of dapsone gel 5% when used with tazarotene cream 0.1% compared with tazarotene cream 0.1% monotherapy in treating moderate to severe facial acne vulgaris
Timeline
- Start
- 2008-12
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dapsone | Small molecule | 5 % | Topical |
| Comparator | Tazarotene | Small molecule | 0.1 % | Topical |